Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation: One-Month DAPT Trial

Authors
Hong, S.-J.Kim, J.-S.Hong, S.J.Lim, D.-S.Lee, S.-Y.Yun, K.H.Park, J.-K.Kang, W.C.Kim, Y.H.Yoon, H.-J.Won, H.Nam, C.-M.Ahn, C.-M.Kim, B.-K.Ko, Y.-G.Choi, D.Jang, Y.Hong, M.-K.One-Month DAPT Investigators
Issue Date
Aug-2021
Publisher
Elsevier Inc.
Keywords
antiplatelet therapy; drug-eluting stent(s); percutaneous coronary intervention
Citation
JACC: Cardiovascular Interventions, v.14, no.16, pp 1801 - 1811
Pages
11
Journal Title
JACC: Cardiovascular Interventions
Volume
14
Number
16
Start Page
1801
End Page
1811
URI
https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/62255
DOI
10.1016/j.jcin.2021.06.003
ISSN
1936-8798
1876-7605
Abstract
Objectives: The aim of this study was to determine whether 1 month of dual-antiplatelet therapy (DAPT) followed by aspirin monotherapy after polymer-free drug-coated stent (PF-DCS) implantation is noninferior to 6 to 12 months of DAPT after biodegradable-polymer drug-eluting stent (BP-DES) implantation. Background: It is necessary to determine the optimal minimal duration of DAPT followed by aspirin monotherapy after percutaneous coronary intervention (PCI). Methods: In this trial, 3,020 patients with coronary artery disease considered for PCI for noncomplex lesions were randomized to 1-month DAPT after PF-DCS (n = 1,507) or 6- to 12-month DAPT after BP-DES (n = 1,513). The primary endpoint was the 1-year composite of cardiac death, nonfatal myocardial infarction, target vessel revascularization, stroke, or major bleeding (noninferiority hypothesis margin of 3%). Results: The primary endpoint occurred in 88 patients (5.9%) in the 1-month DAPT after PF-DCS group and 98 patients (6.5%) in the 6- to 12-month DAPT after BP-DES group (absolute difference −0.7%; upper limit of 1-sided 97.5% confidence interval: 1.33%; P < 0.001 for noninferiority). The occurrence of major bleeding was not different (1.7% vs 2.5%; P = 0.136). There was no difference in the occurrence of stent thrombosis (0.7% vs 0.8%; P = 0.842). Conclusions: Among patients who underwent PCI for noncomplex lesions, 1-month DAPT followed by aspirin monotherapy after PF-DCS implantation was noninferior to 6- to 12-month DAPT after BP-DES implantation for the 1-year composite of cardiovascular events or major bleeding. The present findings need to be interpreted in the setting of different types of stents according to antiplatelet strategy. (A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-Eluting Stent Implantation; NCT02513810) © 2021 American College of Cardiology Foundation
Files in This Item
Appears in
Collections
ETC > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Won, Ho Youn photo

Won, Ho Youn
의과대학 (의학부(임상-서울))
Read more

Altmetrics

Total Views & Downloads

BROWSE